5-Hydroxytryptamine induces contraction in isolated human mammary artery: effect of ketanserin
- PMID: 2285652
- DOI: 10.1007/BF00053428
5-Hydroxytryptamine induces contraction in isolated human mammary artery: effect of ketanserin
Abstract
5-hydroxytryptamine (5HT) treatment produced dose-related contractions in the human internal mammary artery with an EC50 value of 3.4 X 10(-7) M. The 5HT2 receptor antagonist ketanserin reversed the contractions evoked by 5HT in a competitive manner at a low concentration (10(-8) M), whereas a noncompetitive antagonism was apparent at higher concentrations (5 X 10(-8) M to 5 X 10(-7) M). The alpha 1-blocking component of ketanserin was evaluated by studying the effect of ketanserin upon the contractile response evoked by norepinephrine. Up to 10(-7) M, ketanserin did not influence norepinephrine-induced contractions. These findings indicate that the mammary artery is a vascular tissue sensitive to contractions induced by 5HT and that the drug ketanserin antagonizes this contractile response through the 5HT2 receptor subtype.
Similar articles
-
Role of 5-HT2 receptors in serotonin-induced contraction in the human mammary artery.Eur J Pharmacol. 1990 Feb 6;176(2):207-12. doi: 10.1016/0014-2999(90)90529-f. Eur J Pharmacol. 1990. PMID: 2138088
-
Participation of 5-HT1-like and 5-HT2A receptors in the contraction of human temporal artery by 5-hydroxytryptamine and related drugs.Br J Pharmacol. 1996 Jan;117(2):283-92. doi: 10.1111/j.1476-5381.1996.tb15188.x. Br J Pharmacol. 1996. PMID: 8789380 Free PMC article.
-
Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.Br J Pharmacol. 1997 Nov;122(5):875-84. doi: 10.1038/sj.bjp.0701470. Br J Pharmacol. 1997. PMID: 9384503 Free PMC article.
-
Ability of ketanserin to block different receptors in human placental vessels.J Pharm Pharmacol. 1990 Mar;42(3):217-20. doi: 10.1111/j.2042-7158.1990.tb05394.x. J Pharm Pharmacol. 1990. PMID: 1974625
-
Serotonergic antagonists and vascular disease.Cardiovasc Drugs Ther. 1990 Jan;4 Suppl 1:7-12. doi: 10.1007/BF00053420. Cardiovasc Drugs Ther. 1990. PMID: 2285653 Review.